Cancer #Santé #Pharma ailleurs #FDA grants priority review to Roche's leukemia drug - chicagotribune http://t.co/gchb2rDdQN
July 03, 2013
Publicité
/http%3A%2F%2Fsnsimages.tribune.com%2Fmedia%2Fphoto%2F2013-07%2F76543091.jpg)
FDA grants priority review to Roche's leukemia drug
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said on Wednesday U.S. health regulators have granted priority review to its experimental leukemia treatment GA101. The U.S. Food and Drug Administration (FDA) grants priority reviews to medicines that are considered potentially significant therapeutic advancements over existing therapies.